Background
==========

Socioeconomic position (SEP) throughout life is usually inversely associated with morbidity and mortality from cardiovascular disease, although the underlying biological pathway is not entirely clear \[[@B1],[@B2]\]. Cardiovascular disease has been associated with higher levels of inflammatory molecules, perhaps as a consequence of exposure to pathogenic organisms \[[@B3]\], although it is unclear whether pathogen burden mediates SEP differences in cardiovascular risk \[[@B3],[@B4]\]. Poor early life conditions are usually associated with higher levels of inflammatory markers \[[@B5]-[@B11]\] and poorer adult immune function \[[@B12],[@B13]\]. These associations are less clear, however, amongst men from middle income countries \[[@B10]\]. Furthermore, little is known about the association of SEP across the life course with immune function. The duration or number of exposures across the life course may be most important (the accumulation hypothesis) \[[@B14]\]. Alternatively, the timing of exposure to poor socioeconomic conditions may be crucial as a number of sensitive periods or simply as a single critical period (the critical period hypothesis). It is also possible that either inter- or intra-generational social mobility plays a part.

Developmental trade-offs between growth, maintenance, and reproduction may occur when there are competing demands for energy resources between biological systems \[[@B13],[@B15],[@B16]\], potentially at the expense of immune function in resource-poor environments. Alternatively, intergenerationally and environmentally driven up-regulation of the gonadotropic axis with economic development may obscure some of the normally protective effects of social advantage in the first few generations of men to experience better living conditions \[[@B17],[@B18]\], thus generating epidemiologically stage specific associations between SEP and immune-related functions, such as pro-inflammatory states, among men \[[@B18],[@B19]\].

Rapidly developing mega-cities of China may provide a sentinel for the changes in non-communicable diseases expected with economic development and inform effective interventions to reduce the disease burden. In a large sample of older residents from one of the most developed mega-cities in China, Guangzhou in southern China, we assessed the association of SEP at four life stages with proxies of inflammation (total white blood cell, granulocyte, and lymphocyte counts) and compared models representing the accumulation, sensitive periods and critical period hypotheses. Additionally, we hypothesise that 1) higher life course SEP is protective for adult inflammation, 2) the normal protective effect of social advantage is obscured in men experiencing rapid socioeconomic development.

Methods
=======

Sources of data
---------------

The Guangzhou Biobank Cohort Study is a collaboration between the Guangzhou No. 12 Hospital (Guangzhou, China) and the universities of Hong Kong (Hong Kong, China) and Birmingham (Birmingham, United Kingdom). The study has been described previously in detail \[[@B20]\]. Participants were drawn from the Guangzhou Health and Happiness Association for the Respectable Elders (GHHARE), a community social and welfare association unofficially aligned with the municipal government, where membership is open to anyone aged 50 years or older for a nominal monthly fee of 4 yuan (US \$0.50). Approximately 7 percent of permanent Guangzhou residents aged 50 years or more are members of the GHHARE. Eleven percent of the members were included in this study, who were capable of consenting, were ambulatory, and were not receiving treatments which if discontinued might have resulted in immediate, life-threatening risk, such as chemotherapy, radiotherapy or dialysis. Those with less serious chronic illnesses or with acute illnesses were not specifically excluded from the study though they may have been less likely to attend. Participants were recruited in three phases and this study includes participants recruited in phase 3 only (recruited between 2006 and 2008), because only phase 3 has detailed information on childhood socioeconomic position and inflammatory markers.

Participants underwent a detailed half-day medical interview, as well as a physical examination with fasting blood being sampled. Quantitative haematological analysis was performed using a SYSMEX KX-21 haematology analyser. The Guangzhou Medical Ethics Committee of the Chinese Medical Association approved the study and all participants gave written, informed, consent prior to participation.

Socioeconomic position across the life course
---------------------------------------------

We used indicators of SEP at four life stages: childhood, early adult, late adult and current SEP. Childhood SEP was measured by an index of notable parental possessions that were appropriate to China in the mid-20th century, based on sociologic accounts of life in southern China at that time \[[@B17]\]. The items selected were a watch, a sewing machine, and a bicycle. These items were categorized, as previously, as none or at least one \[[@B21]\]. As in other similar studies, we used education and longest-held occupation as proxies for early and late adult SEP \[[@B22]\]. Early adult SEP was assessed from the highest level of education (primary or less versus secondary or more). Occupation was categorised as manual (agricultural work, factory work, or sales and service) or non-manual (administrative/managerial, professional/technical, or military/police). Current SEP was assessed from household income per head. Household income was recorded in six categories (\<5,000 Yuan, 5000-9,999 Yuan, 10,000-19,999 Yuan, 20,000-29,999 Yuan, 30,000-49,999 Yuan and ≥50,000 Yuan). Household income per head was estimated using the mid-point of each income category and assuming that those in the highest category had an annual income of 75,000 Yuan. The median household income per head was used as the cut-off point between low and high SEP.

Outcome measures
----------------

The primary outcome was total white blood cell count used, as in other studies, as a marker of a pro-inflammatory state \[[@B5]\], and less well functioning immune system. As we do not have a detailed breakdown of different white blood cell types, such as macrophages, we also considered granulocyte and lymphocyte counts as outcomes because these immune cell sub-populations largely relate to innate and adaptive immunity respectively. They have previously been used as markers of inflammation \[[@B23],[@B24]\]. Other measures of inflammation (e.g. C-reactive protein) were not available.

Statistical analysis
--------------------

Multivariable linear regression was used to assess the adjusted associations of SEP with the outcomes. Following Mishra et al. \[[@B25]\] we determined the most parsimonious representation of life course SEP by comparing models for three different life course hypotheses (the accumulation, sensitive periods and critical period hypotheses) to a \'fully saturated\' model which represents all possible life course SEP trajectories. As in previous work \[[@B26]\], the accumulation hypothesis was represented by a model representing the number of life stages with high socioeconomic position, and the sensitive periods hypothesis by a model in which all four measures of SEP were considered as separate items in one model adjusted for all four measures of SEP. The critical period hypothesis was represented by models in which only one SEP exposure (the critical period) was included \[[@B25]\]. We used the Akaike Information Criterion (AIC) to compare models \[[@B27]\]. A smaller AIC indicates a better model.

We examined whether the outcomes had different associations with SEP by sex or age, from the heterogeneity across subgroups and the significance of an interaction term obtained from a model including all interaction terms with age or sex. All models were adjusted for age (in 5 year age groups) and sex. A second set of models was additionally adjusted for lifestyle factors (smoking, alcohol use, and physical activity categorized as in Table [1](#T1){ref-type="table"}) as potential mediators and a third set of models additionally adjusted for body mass index (BMI) as a potential mediator

###### 

Characteristics (mean value or percentage) of 9,981 Chinese adults (≥ 50 years) by socioeconomic position at four life stages in women and men from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008

                                                                 Socio-economic position in:                                                                                                                                                                                                                                                                                                  
  ----------------------------- -------------------------------- ---------------------------------------------------------------------------- ----------------------------------- --------------------------------- ----------------------------------------- ----------- ----------- ---------- ------------ ---------------- ------------- ---------- ----------- ----------- ------------- ----------
                                                                 **Childhood(Parental possession of a watch, sewing machine, and bicycle)**   **Early Adulthood (Education\*)**   **Late Adulthood (Occupation)**   **Current (Household Income per Head)**                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                              
                                **No.**                          **0 items**                                                                  **1+ items**                        **Unknown**                       ***p*†**                                  **Low**     **High**    ***p*†**   **Manual**   **Non-manual**   **Unknown**   ***p*†**   **Low**     **High**    **Unknown**   ***p*†**
                                                                                                                                                                                                                                                                                                                                                                                              
  ***Women***                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                              
  Number of participants        7445                             4084                                                                         3123                                238                                                                         3057        4386                   5225         1211             1009                     3025        3141        1279          
  *Mean (SD)*                                                                                                                                                                                                                                                                                                                                                                                 
  White blood cells (10^9^/L)   7445                             6.38(1.5)                                                                    6.13(1.5)                           6.36(1.4)                         \<0.001                                   6.52(1.6)   6.10(1.5)   \<0.001    6.33(1.5)    6.04(1.4)        6.25(1.5)     \<0.001    6.38(1.6)   6.12(1.5)   6.41(1.6)     \<0.001
  Granulocytes (10^9^/L)        7445                             3.79(1.2)                                                                    3.62(1.2)                           3.71(1.1)                         \<0.001                                   3.89(1.2)   3.60(1.1)   \<0.001    3.76(1.2)    3.53(1.1)        3.71(1.2)     \<0.001    3.79(1.2)   3.60(1.1)   3.84(1.2)     \<0.001
  Lymphocytes (10^9^/L)         7445                             2.19(0.6)                                                                    2.15(0.6)                           2.26(0.6)                         \<0.001                                   2.22(0.6)   2.14(0.6)   \<0.001    2.18(0.6)    2.15(0.6)        2.18(0.6)     0.227      2.20(0.6)   2.16(0.6)   2.16(0.6)     0.008
  Leg length (cm)               7430                             69.7(3.8)                                                                    69.8(3.6)                           69.8(4.3)                         0.393                                     69.6(3.8)   69.8(3.7)   0.008      69.7(3.7)    69.9(3.6)        69.6(3.8)     0.202      69.6(3.8)   69.8(3.6)   69.6(3.8)     0.099
  Sitting height (cm)           7431                             83.7(3.6)                                                                    85.1(3.1)                           84.1(3.7)                         \<0.001                                   83.1(3.6)   85.1(3.1)   \<0.001    84.0(3.5)    85.0(3.3)        84.6(3.3)     \<0.001    83.9(3.5)   85.0(3.2)   83.5(3.7)     \<0.001
  *Row%*                                                                                                                                                                                                                                                                                                                                                                                      
  **Age group (years)**                                                                                                                                                                                                                                                                                                                                                                       
  *50-54*                       2644                             36.0                                                                         60.7                                3.3                                                                         17.9        82.1                   65.0         18.5             16.5                     36.0        53.0        11.1          
  *55-59*                       1892                             52.7                                                                         44.5                                2.7                                                                         39.1        60.9                   69.8         17.2             12.9                     39.0        44.2        16.8          
  *60-64*                       1133                             64.9                                                                         32.7                                2.5                                                                         51.5        48.5                   73.8         14.7             11.6                     46.5        34.6        18.9          
  *65-69*                       833                              74.5                                                                         21.5                                4.0                                                                         63.5        36.4                   76.1         13.8             10.1                     46.2        29.7        24.1          
  *70-74*                       621                              82.8                                                                         13.4                                3.9                                                                         75.7        24.3                   75.0         13.7             11.3                     44.8        28.3        26.9          
  *75-79*                       228                              82.0                                                                         14.5                                3.5                                                                         81.1        18.4                   75.9         10.5             13.6                     49.1        25.0        25.9          
  *80+*                         94                               80.9                                                                         12.8                                6.4                               \<0.001                                   81.9        18.1        \<0.001    81.9         5.3              12.8          \<0.001    37.2        34.0        28.7          \<0.001
  **Alcohol use**                                                                                                                                                                                                                                                                                                                                                                             
  Never                         3981                             57.9                                                                         39.1                                3.1                                                                         45.9        54.1                   71.7         15.2             13.1                     43.8        37.8        18.4          
  \<1/week                      2811                             49.8                                                                         47.1                                3.2                                                                         33.8        66.2                   67.4         18.1             14.5                     36.7        48.4        14.9          
  1-4/week                      162                              53.1                                                                         40.7                                6.2                                                                         35.2        64.8                   72.8         16.7             10.5                     35.8        47.5        16.7          
  5+/week                       126                              63.5                                                                         33.3                                3.2                                                                         43.7        56.3                   70.6         13.5             15.9                     34.1        46.8        19.0          
  Ex-drinker                    196                              62.8                                                                         34.7                                2.6                               \<0.001                                   50.5        49.5        \<0.001    78.1         11.2             10.7          0.001      44.4        35.2        20.4          \<0.001
  *Unknown*                     169                              54.4                                                                         40.8                                4.7                                                                         41.4        57.4                   68.6         17.8             13.6                     36.1        43.2        20.7          
  **Smoking status**                                                                                                                                                                                                                                                                                                                                                                          
  *Never*                       7192                             54.5                                                                         42.4                                3.1                                                                         40.1        59.9                   70.0         16.4             13.5                     40.4        42.5        17.1          
  *Ex-smoker*                   95                               76.8                                                                         18.9                                4.2                                                                         87.4        12.6                   77.9         6.3              15.8                     46.3        27.4        26.3          
  *Current*                     106                              63.2                                                                         28.3                                8.5                               \<0.001                                   65.1        34.9        \<0.001    79.2         12.3             8.5           0.013      55.7        27.4        17.0          \<0.001
  *Unknown*                     52                               48.1                                                                         46.2                                5.8                                                                         38.5        57.7                   61.5         17.3             21.2                     34.6        51.9        13.5          
  **Physical activity**                                                                                                                                                                                                                                                                                                                                                                       
  *Inactive*                    626                              55.4                                                                         40.7                                3.8                                                                         42.8        56.9                   71.4         15.8             12.8                     40.3        38.0        21.7          
  *Minimally active*            1848                             54.9                                                                         42.0                                3.1                                                                         41.5        58.5                   70.1         17.4             12.6                     41.7        41.3        16.9          
  *HEPA active^\$^*             4971                             54.8                                                                         42.1                                3.2                               0.877                                     40.7        59.3        0.520      70.1         15.9             14.0          0.450      40.3        43.0        16.7          0.249
                                                                                                                                                                                                                                                                                                                                                                                              
                                **Socio-economic position in**                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                              
                                                                 **Childhood(Parental possession of a watch, sewing machine, and bicycle**    **Early Adulthood (Education\*)**   **Late Adulthood (Occupation)**   **Current (Household Income per Head)**                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                              
                                **No.**                          **0 items**                                                                  **1+ items**                        **Unknown**                       ***p*†**                                  **Low**     **High**    ***p*†**   **Manual**   **Non-manual**   **Unknown**   ***p*†**   **Low**     **High**    **Unknown**   ***p*†**
                                                                                                                                                                                                                                                                                                                                                                                              
  ***Men***                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                              
  Number of participants        2536                             1664                                                                         812                                 60                                                                          730         1803                   1581         791              164                      1131        1035        370           
  *Mean (SD)*                                                                                                                                                                                                                                                                                                                                                                                 
  White blood cells (10^9^/L)   2536                             6.85(1.7)                                                                    6.86(1.7)                           6.74(1.5)                         0.878                                     7.01(1.7)   6.79(1.7)   0.010      6.87(1.7)    6.75(1.7)        7.15(1.9)     0.021      6.93(1.7)   6.73(1.7)   6.95(1.7)     0.012
  Granulocytes (10^9^/L)        2536                             4.21(1.4)                                                                    4.14(1.4)                           4.17(1.1)                         0.439                                     4.38(1.4)   4.11(1.3)   \<0.001    4.21(1.4)    4.10(1.3)        4.40(1.6)     0.018      4.27(1.4)   4.07(1.3)   4.27(1.4)     0.002
  Lymphocytes (10^9^/L)         2536                             2.14(0.6)                                                                    2.23(0.7)                           2.05(0.5)                         0.002                                     2.10(0.6)   2.19(0.7)   0.006      2.16(0.7)    2.17(0.6)        2.23(0.6)     0.389      2.15(0.7)   2.18(0.6)   2.18(0.7)     0.619
  Leg length (cm)               2519                             75.2(3.8)                                                                    75.7(4.2)                           75.3(3.7)                         0.005                                     74.6(3.7)   75.6(4.0)   \<0.001    75.2(3.9)    75.6(4.0)        75.6(3.9)     0.020      75.1(4.0)   75.7(3.8)   75.1(4.0)     0.003
  Sitting height (cm)           2520                             88.6(3.6)                                                                    89.8(3.4)                           88.7(3.7)                         \<0.001                                   87.6(3.5)   89.6(3.4)   \<0.001    88.8(3.6)    89.3(3.4)        89.7(4.0)     \<0.001    88.5(3.5)   89.7(3.4)   88.6(3.8)     \<0.001
  *Row%*                                                                                                                                                                                                                                                                                                                                                                                      
  **Age group (years)**                                                                                                                                                                                                                                                                                                                                                                       
  *50-54*                       346                              41.3                                                                         56.6                                2.0                                                                         11.3        88.7                   68.8         21.4             9.8                      43.9        42.8        13.3          
  *55-59*                       568                              57.0                                                                         41.0                                1.9                                                                         23.6        76.4                   67.3         25.4             7.4                      44.9        43.0        12.1          
  *60-64*                       599                              65.4                                                                         32.2                                2.3                                                                         25.2        74.6                   61.3         32.9             5.8                      37.4        47.9        14.7          
  *65-69*                       470                              76.0                                                                         22.3                                1.7                                                                         30.6        69.1                   56.8         38.5             4.7                      48.5        37.0        14.5          
  *70-74*                       339                              82.3                                                                         15.3                                2.4                                                                         44.5        55.5                   58.7         36.3             5.0                      48.7        32.2        19.2          
  *75-79*                       156                              78.2                                                                         16.0                                5.8                                                                         51.3        48.1                   60.9         32.1             7.1                      48.1        35.9        16.0          
  *80+*                         58                               81.0                                                                         13.8                                5.2                               \<0.001                                   53.4        46.6        \<0.001    56.9         37.9             5.2           \<0.001    55.2        29.3        15.5          \<0.001
  **Alcohol use**                                                                                                                                                                                                                                                                                                                                                                             
  Never                         880                              68.3                                                                         29.9                                1.8                                                                         30.1        69.9                   61.0         32.0             6.9                      48.1        36.8        15.1          
  \<1/week                      1068                             63.2                                                                         34.7                                2.1                                                                         24.4        75.6                   61.5         32.0             6.5                      41.5        44.4        14.1          
  1-4/week                      176                              62.5                                                                         34.7                                2.8                                                                         25.6        74.4                   67.6         28.4             4.0                      46.0        44.9        9.1           
  5+/week                       271                              65.7                                                                         32.5                                1.8                                                                         39.9        60.1                   66.4         28.8             4.8                      43.9        39.9        16.2          
  Ex-drinker                    93                               71.0                                                                         21.5                                7.5                               0.046                                     37.6        62.4        \<0.001    67.7         24.7             7.5           0.323      49.5        34.4        16.1          0.011
  *Unknown*                     48                               70.8                                                                         18.8                                10.4                                                                        33.3        60.4                   52.1         33.3             14.6                     39.6        37.5        22.9          
  **Smoking status**                                                                                                                                                                                                                                                                                                                                                                          
  *Never*                       940                              63.8                                                                         34.3                                1.9                                                                         20.3        79.7                   58.3         35.3             6.4                      41.0        45.5        13.5          
  *Ex-smoker*                   675                              69.0                                                                         28.1                                2.8                                                                         33.5        66.5                   62.2         31.3             6.5                      46.2        40.4        13.3          
  *Current*                     900                              65.1                                                                         32.9                                2.0                               0.039                                     34.3        65.7        \<0.001    66.8         27.0             6.2           \<0.001    47.6        36.2        16.2          \<0.001
  *Unknown*                     21                               57.1                                                                         19.0                                23.8                                                                        19.0        66.7                   57.1         23.8             19.0                     28.6        38.1        33.3          
  **Physical activity**                                                                                                                                                                                                                                                                                                                                                                       
  *Inactive*                    223                              65.9                                                                         31.4                                2.7                                                                         31.8        66.8                   68.6         26.0             5.4                      48.4        30.9        20.6          
  *Minimally active*            866                              61.1                                                                         36.4                                2.5                                                                         29.1        70.9                   58.8         33.9             7.3                      44.3        40.9        14.8          
  *HEPA active^\$^*             1447                             68.3                                                                         29.5                                2.2                               0.002                                     28.1        71.9        0.438      63.5         30.3             6.2           0.021      44.2        42.3        13.5          0.046

\* Highest level of education was categorised as low (primary or less) and high (above primary)

\# Manual is agricultural worker, factory worker or sales and service, non-manual is administrator/manager, professional/technical or military/disciplined

† p value for linear trend for continuous variables and *χ*^2^p value for categorical variables

*\$*Health enhancing physical activity: vigorous activity at least 3 days a week achieving at least 1500 metabolically equivalent tasks (MET) minutes per week or activity on 7 days of the week achieving at least 3000 MET minutes per week

Proxies of SEP were unavailable or unclassifiable for 28.7% of the participants, mainly because information on household income or the longest-held occupation was missing. Alcohol use or smoking was not available for 2% of participants. We used multiple imputation for missing data \[[@B28],[@B29]\]. Socioeconomic position at any stage, alcohol use and smoking were predicted based on a flexible additive regression model with predictive mean matching incorporating age, sex, leg length, seated height, alcohol use, smoking status, physical activity and SEP at the other three stages \[[@B28]\]. We imputed missing values 10 times and analysed each complete dataset separately, then summarized estimates with confidence intervals adjusted for missing data uncertainty \[[@B30]\]. As a sensitivity analysis, a complete case analysis without imputation was performed. We used STATA version 10.0 (STATA Corp., College Station, TX) and R version 2.12.2 for analysis, imputation and model estimation.

Results
=======

Of the 10,088 phase 3 participants examined, 1.1% (*n*= 107) had missing data for total white blood cell, granulocyte or lymphocyte counts. Analysis was based on the remaining 9,981 participants. There were more women (*n*= 7,445) than men (*n*= 2,536) and the women were younger \[mean age 59.2 years (S.D. 7.6)\] than the men \[mean age 63.1 years (S.D. 7.6)\]. Overall the mean white blood cell and granulocyte counts were lower in women than men (Table [1](#T1){ref-type="table"}).

The associations of SEP with white blood cell, granulocyte or lymphocyte counts did not vary with age (data not shown). However, associations of SEP with lymphocyte count varied with sex, so only sex stratified results have been presented for this outcome. For white blood cell count and granulocyte count, the sensitive periods model performed better than the fully saturated model, accumulation or critical period models (Table [2](#T2){ref-type="table"}). The sensitive periods model shows that some life stages had stronger negative associations than others with white blood cell count and granulocyte count; the early adult stage had the strongest association for both outcomes.

###### 

Associations of high socioeconomic position (compared to low) at four life stages with white cell count and its differentials, adjusted for age^a^and sex in 9,981 Chinese adults (≥ 50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008

                                           White Blood Cell Count (10^9^/L)                          Granulocyte Cell Count (10^9^/L)   
  ---------------------------- ----------- ---------------------------------- ---------- ----------- ---------------------------------- ----------
                               **Δ**       **95% CI**                         **AIC**    **Δ**       **95% CI**                         **AIC**
                                                                                                                                        
  **Men and Women**                                                                                                                     
  Critical period Model^b^                                                                                                              
  *Childhood*                  **-0.14**   **(-0.20, -0.07)**                 8995       **-0.10**   **(-0.15, -0.04)**                 4095
  *Early Adult*                **-0.35**   **(-0.42, -0.29)**                 8909       **-0.26**   **(-0.31, -0.21)**                 4018
  *Late Adult*                 **-0.21**   **(-0.29, -0.13)**                 8980       **-0.17**   **(-0.23, -0.11)**                 4074
  *Current*                    **-0.22**   **(-0.29, -0.15)**                 8965       **-0.16**   **(-0.22, -0.11)**                 4064
  Accumulation Model*^c^*                                                     8905                                                      4012
  *0*                          0                                                         0                                              
  *1*                          **-0.19**   **(-0.29, -0.09)**                            **-0.14**   **(-0.22, -0.06)**                 
  *2*                          **-0.32**   **(-0.42, -0.22)**                            **-0.23**   **(-0.31, -0.16)**                 
  *3*                          **-0.48**   **(-0.58, -0.38)**                            **-0.35**   **(-0.43, -0.27)**                 
  *4*                          **-0.51**   **(-0.65, -0.38)**                            **-0.40**   **(-0.50, -0.29)**                 
  Sensitive Periods Model^d^                                                  **8892**                                                  **4000**
  *Childhood*                  -0.06       (-0.13, 0.01)                                 -0.03       (-0.09, 0.02)                      
  *Early Adult*                **-0.28**   **(-0.36, -0.20)**                            **-0.20**   **(-0.26, -0.14)**                 
  *Late Adult*                 -0.08       (-0.17, 0.002)                                **-0.08**   **(-0.14, -0.01)**                 
  *Current*                    **-0.12**   **(-0.19, -0.05)**                            **-0.09**   **(-0.15, -0.04)**                 
  Fully Saturated Model^e^                                                    8905                                                      4015

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

\* Test for interaction with sex significant at p \< 0.05 level

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age and sex but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age and sex. ^d^Mutually adjusted for SEP at other life stages and adjusted for age and sex. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age and sex

The pattern for lymphocyte cell count was somewhat different. Associations varied by sex. Table [3](#T3){ref-type="table"} shows that for both sexes the accumulation and sensitive periods models did not perform as well as critical period models. The early adult life stage was a critical period for women, with a negative association between SEP and lymphocyte cell count. By contrast, for men, all estimates of association between SEP and lymphocyte cell count were positive, although all confidence intervals included zero.

###### 

Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count (10^9^/L) by sex, adjusted for age^a^in 9,981 Chinese adults (≥ 50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008

                               Women (n = 7,445)   Men (n = 2,536)                                              
  ---------------------------- ------------------- ------------------------ ----------- ------- --------------- -----------
                               **Δ**               **95% CI**               **AIC**     **Δ**   **95% CI**      **AIC**
                                                                                                                
  Critical period Model^b^                                                                                      
   *Childhood*                 **-0.04**           **(-0.07**, **-0.01)**   -7874       0.03    (-0.03, 0.08)   -2277
   *Early Adult*               **-0.08**           **(-0.11**, **-0.05)**   **-7894**   0.03    (-0.02, 0.09)   -2277
   *Late Adult*                -0.03               (-0.07, 0.01)            -7871       0.04    (-0.01, 0.10)   **-2279**
   *Current*                   **-0.04**           **(-0.07**, **-0.01)**   -7874       0.01    (-0.05 0.07)    -2277
  Accumulation Model*^c^*                                                   -7885                               -2274
   *0*                         0                                                        0                       
   *1*                         -0.02               (-0.07, 0.02)                        0.02    (-0.07, 0.11)   
   *2*                         **-0.05**           **(-0.10**, **-0.01)**               0.05    (-0.03, 0.13)   
   *3*                         **-0.10**           **(-0.14**, **-0.05)**               0.04    (-0.05, 0.12)   
   *4*                         **-0.09**           **(-0.15**, **-0.03)**               0.10    (-0.01, 0.21)   
  Sensitive Periods Model^d^                                                -7891                               -2274
   *Childhood*                 -0.02               (-0.05, 0.01)                        0.02    (-0.03, 0.08)   
   *Early Adult*               **-0.07**           **(-0.10**, **-0.04)**               0.02    (-0.04, 0.08)   
   *Late Adult*                0.00                (-0.04, 0.04)                        0.04    (-0.02, 0.10)   
   *Current*                   -0.01               (-0.05, 0.02)                        0.00    (-0.06, 0.06)   
  Fully Saturated Model^e^                                                  -7882                               -2262

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age. ^d^Mutually adjusted for SEP at other life stages and adjusted for age ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age

Additional adjustment for lifestyle factors (smoking, alcohol use, and physical exercise) attenuated estimates slightly (see Appendix) but the pattern of associations generally remained the same. Smoking among men is associated with both low SEP and higher lymphocyte count, hence adjustment for smoking strengthened the positive association of SEP with lymphocyte count (Appendix). Further adjustment for BMI (Appendix) produced very similar results; estimates of association were little changed. All results were similar in a complete case analysis (Appendix).

Discussion
==========

Consistent with other studies in developed and developing settings examining the association between SEP and inflammation \[[@B5]-[@B11]\], we found that SEP was negatively associated with adult immune cell numbers, particularly among women. Consistent with the only other study from a developing country setting, the advantage of higher SEP for adult inflammation was less marked among men \[[@B10]\]. In general, considering SEP at all four life stages was better than considering individual life stages (critical periods) except for lymphocyte cell counts.

This study has a number of strengths. To our knowledge, it is the first study to investigate the role of life course SEP in later adulthood inflammation in a non-western, developing setting. Moreover, we explicitly determined the most parsimonious representation of life course SEP. The large sample size allowed sex-specific analysis. Nevertheless, there are limitations. First, it is a cross-sectional study with recalled SEP, which may be imprecise, although most likely non-differential. Second, in a cross-sectional design reverse causality must be considered although it is unlikely that inflammation has a causal effect on life course SEP. Third, there may have been gender bias in the allocation of resources within families, most likely favouring boys and men, which may have mitigated the disadvantages of low SEP. However it is unclear why this should have mitigated the effect of SEP for lymphocytes but not for white blood cells and granulocytes. Fourth, our cohort may not be fully population representative. However, prevalence of certain morbidities, such as diabetes, were similar to those in a representative sample of urban Chinese \[[@B31]\]. Fifth, survivor bias is possible, which may have limited participants\' socioeconomic and health diversity, biasing results towards the null. If survivorship were an issue we would have expected differences in associations by age, of which there was no evidence. Sixth, we did not explicitly consider the life course effects of social mobility since these are particularly hard to define and test clearly. Inter- and intra-generational mobility, upward and downward mobility are all potential risk factors.

Seventh, a single measurement of white blood cells and differential cell counts may not accurately reflect long-term immune function or inflammation. However, white blood cell count is used as a marker of immune status in clinical settings and is a well-established and routinely-used marker of systemic inflammation \[[@B32]\]. White blood cell count is associated with disease risk and predicts disease outcome \[[@B33],[@B34]\]. Eighth, although we report associations between SEP and differential white blood cell counts, clinical significance remains to be determined. Within the normal range, elevated white blood cell counts are associated with risk factors for chronic diseases, such as cardiovascular disease \[[@B32],[@B35]\]. White blood cell counts can be conceptualised as a mixed marker of exposure and response, even a relatively small shift towards a healthier inflammation-immunological profile might have significant public health benefits at the population level \[[@B33],[@B34]\]. Ninth, acute infection, trauma and underlying chronic disease or medication could be mediators. There is no evidence to suggest that participants were experiencing infection during the assessment process, nor significant trauma. Although only those with life-threatening illness were specifically excluded, those experiencing significant acute infection or trauma were less likely to attend this study, which should have minimized any bias from this source. We also performed descriptive analysis of the data to detect and exclude outliers, which may have resulted from unknown underlying disease, medication, or recording error.

One possible explanation for the association of low SEP with inflammation is via current health behaviour linked to inflammation \[[@B5],[@B36]-[@B38]\]. Although we did not perform formal tests of mediation, we did adjust for smoking, alcohol consumption, physical activity and BMI in separate models (Appendix), which had little effect among women, but among men, this attenuated the negative association of early adult SEP with white blood cell and granulocyte counts and strengthened the positive association of early adult SEP with lymphocyte counts. This suggests that any associations are unlikely to be driven by adult health behaviour in women, though these may obscure negative associations of early adult SEP with inflammatory markers in men.

Low SEP may increase exposure to pro-inflammatory agents, such as microbial pathogens, pollutants or adverse work conditions. Mechanisms for increased exposure or vulnerability to pathogens in low SEP groups include earlier and/or greater lifetime exposure due to adverse living conditions, such as overcrowding, and increased susceptibility to primary infection through nutritional deficiencies, or stress-related immune dysfunction \[[@B3]\]. A gender bias may have protected low SEP men from such exposures and adverse work conditions, although it is not clear why the effects should be most obvious for lymphocytes. Lower birth weight amongst those with low childhood SEP is another possible explanation, but birth weight is not available for our participants. Birth weight is inversely associated with inflammatory markers \[[@B6],[@B39]\]. However, birth weight appears to be less relevant in developing country settings such as ours \[[@B40]\], and there is no reason why birth weight should have sex-specific effects on some white cell sub-types.

An alternative explanation is that better early life conditions would be expected to promote development of the adaptive immune system, particularly of the thymus,\[[@B41]\] whose development takes place in early life \[[@B41]\] and which is sensitive to malnutrition, micro-nutrient deficiencies and infections during growth and development \[[@B42]-[@B44]\]. Moreover, the same exposure would also allow upregulation of the gonadotropic axis resulting in sex-specific effects on some immune cell sub-populations \[[@B45]-[@B47]\], particularly those relating to adaptive immunity. Consistent with this mechanism we have previously observed similar sex-specific associations, in the Guangzhou Biobank Cohort Study, of childhood stress with white cell count \[[@B48]\] and of childhood diet with lymphocytes but not granulocytes \[[@B19]\]. However, we do not have measurements that would allow proof of this mechanism.

Conclusions
===========

Socioeconomic position was inversely associated with white blood cell differential counts, as a marker of inflammation, with a clearer and more consistent association among women than men. Environmentally and inter-generationally driven changes to the gonadotropic axis may obscure the normally protective effect of social advantage in the first few generations of men, but not women, to experience better living conditions. Given the links between the immune system, inflammation and chronic disease, this provides a biological mechanism between SEP and the pathophysiological genesis of chronic disease. Understanding such mechanisms for populations experiencing the epidemiological transition is of public health significance.
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Appendix
========

Associations of socioeconomic position with markers of inflammation, additionally adjusted for lifestyles factors (smoking, alcohol use and physical exercise), are shown below: associations with white cell counts and granulocyte counts are shown in Table [4](#T4){ref-type="table"} and sex-specific associations with lymphocyte counts are shown in Table [5](#T5){ref-type="table"}. Associations further adjusted for body mass index are shown in Table [6](#T6){ref-type="table"} (for white cell count and granulocyte count) and Table [7](#T7){ref-type="table"} (lymphocyte count). Results from the complete case analysis are shown in below in Table [8](#T8){ref-type="table"} (white cell count and granulocyte count) and Table [9](#T9){ref-type="table"} (lymphocyte count).

###### 

Associations of high socioeconomic position compared to low at four life stages with white cell count and granulocyte count, adjusted for age^a^, sex and lifestyle factors in 9,981 Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008

                               White Blood Cell Count (10^9^/L)   Granulocyte Cell Count (10^9^/L)                                                   
  ---------------------------- ---------------------------------- ---------------------------------- ---------- ----------- ------------------------ ----------
                               **Δ**                              **95% CI**                         **AIC**    **Δ**       **95% CI**               **AIC**
                                                                                                                                                     
  **Men and Women**                                                                                                                                  
  Critical Period Model^b^                                                                                                                           
   *Childhood*                 **-0.13**                          **(-0.19**, **-0.06)**             8789       **-0.09**   **(-0.14**, **-0.04)**   3967
   *Early Adult*               **-0.31\***                        **(-0.38**, **-0.24)**             8725       **-0.23**   **(-0.29**, **-0.18)**   3907
   *Late Adult*                **-0.18\***                        **(-0.27**, **-0.10)**             8779       **-0.16**   **(-0.22**, **-0.09)**   3951
   *Current*                   **-0.18**                          **(-0.25**, **-0.12)**             8769       **-0.15**   **(-0.20**, **-0.09)**   3944
  Accumulation Model*^c^*                                                                            8722                                            3901
   *0*                         0                                                                                0                                    
   *1*                         **-0.17**                          **(-0.27**, **-0.07)**                        **-0.13**   **(-0.21**, **-0.05)**   
   *2*                         **-0.28**                          **(-0.37**, **-0.18)**                        **-0.21**   **(-0.28**, **-0.13)**   
   *3*                         **-0.42**                          **(-0.52**, **-0.32)**                        **-0.32**   **(-0.40**, **-0.24)**   
   *4*                         **-0.46**                          **(-0.59**, **-0.32)**                        **-0.37**   **(-0.47**, **-0.26)**   
  Sensitive Periods Model^d^                                                                         **8713**                                        **3892**
   *Childhood*                 -0.06                              (-0.13, 0.01)                                 -0.04       (-0.09, 0.02)            
   *Early Adult*               **-0.24**                          **(-0.32**, **-0.17)**                        **-0.18**   **(-0.24**, **-0.12)**   
   *Late Adult*                -0.08                              (-0.16, 0.01)                                 **-0.07**   **(-0.14**, **-0.01)**   
   *Current*                   **-0.10**                          **(-0.18**, **-0.03)**                        **-0.08**   **(-0.14**, **-0.02)**   
  Fully Saturated Model^e^                                                                           8725                                            3907

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs \* Test for interaction with sex significant at p \< 0.05 level

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age, sex, smoking, alcohol use, and physical activity but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age, sex, smoking, alcohol use, and physical activity. ^d^Mutually adjusted for SEP at other life stages and adjusted for age, sex, smoking, alcohol use, and physical activity. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age, sex, smoking, alcohol use, and physical activity

###### 

Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count (10^9^/L) by sex, adjusted for age^a^and lifestyle factors in 9,981 Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008

                               Women (n = 7,445)                         Men (n = 2,536)                                  
  ---------------------------- ------------------- --------------------- ----------------- ---------- ------------------- -----------
                               **Δ**               **95% CI**            **AIC**           **Δ**      **95% CI**          **AIC**
                                                                                                                          
  Critical period Model^b^                                                                                                
   *Childhood*                 **-0.03**           **(-0.06, -0.01)**    -7876             0.03       (-0.02, 0.09)       -2354
   *Early Adult*               **-0.08**           **(-0.11, -0.05)**    **-7894**         **0.07**   **(0.02, 0.13)**    **-2360**
   *Late Adult*                -0.03               (-0.07, 0.01)         -7873             **0.06**   **(0.003, 0.11)**   -2358
   *Current*                   **-0.03**           **(-0.06, -0.001)**   -7876             0.03       (-0.02, 0.09)       -2355
  Accumulation Model*^c^*                                                -7885                                            -2357
   *0*                         0                                                           0                              
   *1*                         -0.02               (-0.07, 0.02)                           0.04       (-0.05, 0.12)       
   *2*                         **-0.05**           **(-0.10, -0.01)**                      **0.08**   **(0.004, 0.16)**   
   *3*                         **-0.09**           **(-0.13, -0.04)**                      **0.08**   **(0.001, 0.17)**   
   *4*                         **-0.09**           **(-0.14, -0.03)**                      **0.15**   **(0.03, 0.26)**    
  Sensitive Periods Model^d^                                             -7891                                            -2357
   *Childhood*                 -0.02               (-0.05, 0.01)                           0.02       (-0.03, 0.08)       
   *Early Adult*               **-0.07**           **(-0.10, -0.03)**                      0.06       (-0.01, 0.12)       
   *Late Adult*                0.00                (-0.04, 0.04)                           0.04       (-0.02, 0.10)       
   *Current*                   -0.01               (-0.04, 0.02)                           0.01       (-0.05, 0.07)       
  Fully Saturated Model^e^                                               -7881                                            -2345

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age, smoking, alcohol use, and physical activity but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age, smoking, alcohol use, and physical activity. ^d^Mutually adjusted for SEP at other life stages and adjusted for age, smoking, alcohol use, and physical activity. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age, smoking, alcohol use, and physical activity

###### 

Associations of high socioeconomic position (compared to low) at four life stages with white cell count and granulocyte count, adjusted for age^a^, sex and lifestyle factors and body mass index in 9,981 Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008

                                           White Blood Cell Count (10^9^/L)                            Granulocyte Cell Count (10^9^/L)   
  ---------------------------- ----------- ---------------------------------- ------------ ----------- ---------------------------------- ----------
                               **Δ**       **95% CI**                         **AIC**      **Δ**       **95% CI**                         **AIC**
                                                                                                                                          
  **Men and Women**                                                                                                                       
  Critical period Model^b^                                                                                                                
   *Childhood*                 **-0.13**   **(-0.19**, **-0.06)**             8248         **-0.09**   **(-0.14**, **-0.04)**             3675
   *Early Adult*               **-0.31**   **(-0.38**, **-0.24)**             8206         **-0.24**   **(-0.29**, **-0.18)**             3631
   *Late Adult*                **-0.20**   **(-0.27**, **-0.12)**             8239         **-0.17**   **(-0.23**, **-0.10)**             3659
   *Current*                   **-0.20**   **(-0.27**, **-0.14)**             8223         **-0.16**   **(-0.21**, **-0.11)**             3646
  Accumulation Model*^c^*                                                                                                                 3611
   *0*                         0                                              8186.0       0                                              
   *1*                         **-0.19**   **(-0.29**, **-0.09)**                          **-0.14**   **(-0.22**, **-0.06)**             
   *2*                         **-0.28**   **(-0.37**, **-0.18)**                          **-0.21**   **(-0.29**, **-0.14)**             
   *3*                         **-0.40**   **(-0.50**, **-0.30)**                          **-0.31**   **(-0.39**, **-0.23)**             
   *4*                         **-0.42**   **(-0.56**, **-0.29)**                          **-0.35**   **(-0.45**, **-0.24)**             
  Sensitive Periods Model^d^                                                  **8185.9**                                                  **3608**
   *Childhood*                 -0.06       (-0.13, 0.01)                                   -0.04       (-0.09, 0.02)                      
   *Early Adult*               **-0.18**   **(-0.25**, **-0.10)**                          **-0.14**   **(-0.20**, **-0.08)**             
   *Late Adult*                -0.08       (-0.16, 0.00)                                   **-0.08**   **(-0.14**, **-0.02)**             
   *Current*                   **-0.12**   **(-0.20**, **-0.05)**                          **-0.10**   **(-0.15**, **-0.05)**             
  Fully Saturated Model^e^                                                    8198                                                        3624

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age, sex, smoking, alcohol use, and physical activity and body mass index but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age, sex, smoking, alcohol use, and physical activity and body mass index. ^d^Mutually adjusted for SEP at other life stages and adjusted for age, sex, smoking, alcohol use, and physical activity and body mass index. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age, sex, smoking, alcohol use, and physical activity

###### 

Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count (10^9^/L) by sex, adjusted for age^a^, lifestyle factors and body mass index in 9,981 Chinese adults(≥50 years) from the Guangzhou Biobank Cohort Study, phase3, 2006-2008

                               Women (n = 7,445)                              Men (n = 2,536)                                      
  ---------------------------- ------------------- -------------------------- ----------------- ---------- ----------------------- -----------
                               **Δ**               **95% CI**                 **AIC**           **Δ**      **95% CI**              **AIC**
                                                                                                                                   
  Critical period Model^b^                                                                                                         
   *Childhood*                 **-0.03**           **(-0.06**, **-0.01)**     -8283             0.03       (-0.02, 0.09)           -2438
   *Early Adult*               **-0.08**           **(-0.11**, **-0.05)**     **-8288**         **0.07**   **(0.02**, **0.13)**    **-2443**
   *Late Adult*                -0.03               (-0.06, 0.01)              -8278             **0.05**   **(0.00**, **0.11)**    -2440
   *Current*                   **-0.03**           **(-0.06**, **-0.01)**     -8281             0.03       (-0.02, 0.09)           -2438
  Accumulation Model*^c^*                                                     -8284                                                -2439
   *0*                         0\*                                                              0\*                                
   *1*                         -0.03               (-0.08, 0.01)                                0.02       (-0.06, 0.10)           
   *2*                         -0.04               (-0.08, 0.002)                               0.07       (-0.01, 0.15)           
   *3*                         **-0.07**           **(-0.12**, **-0.02)**                       0.07       (-0.02, 0.15)           
   *4*                         **-0.06**           **(-0.12**, **-0.0003)**                     **0.13**   **(0.02**, **0.24)**    
  Sensitive Periods Model^d^                                                  -8285                                                -2440
   *Childhood*                 -0.02               (-0.05, 0.01)                                0.02       (-0.04, 0.08)           
   *Early Adult*               **-0.04**           **(-0.07**, **-0.01)**                       **0.06**   **(0.002**, **0.12)**   
   *Late Adult*                0.01                (-0.03, 0.05)                                0.03       (-0.03, 0.09)           
   *Current*                   -0.01               (-0.04, 0.02)                                0.00       (-0.06, 0.06)           
  Fully Saturated Model^e^                                                    -8274                                                -2428

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age, smoking, alcohol use, and physical activity and body mass index but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age, smoking, alcohol use, and physical activity and body mass index. ^d^Mutually adjusted for SEP at other life stages and adjusted for age, smoking, alcohol use, and physical activity and body mass index. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age, smoking, alcohol use, and physical activity

###### 

Associations of high socioeconomic position (compared to low) at four life stages with white cell count and its differentials, adjusted for age^a^and sex Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008 including complete cases only

                                       White Blood Cell Count (10^9^/L)                                      Granulocyte Cell Count (10^9^/L)                                        
  ---------------------------- ------- ---------------------------------- ------------------------ --------- ---------------------------------- ----------- ------------------------ ---------
                               **N**   **Δ**                              **95% CI**               **AIC**   **N**                              **Δ**       **95% CI**               **AIC**
                                                                                                                                                                                     
  **Men and Women**                                                                                                                                                                  
  Critical period Model^b^                                                                                                                                                           
   *Childhood*                 9683    **-0.14**                          **(-0.21**, **-0.07)**   8769      9683                               **-0.10**   **(-0.15**, **-0.04)**   4038
   *Early Adult*               9976    **-0.35**                          **(-0.42**, **-0.29)**   8906      9976                               **-0.26**   **(-0.31**, **-0.21)**   4018
   *Late Adult*                8808    **-0.23**                          **(-0.31**, **-0.15)**   7901      8808                               **-0.19**   **(-0.25**, **-0.12)**   3575
   *Current*                   8332    **-0.23**                          **(-0.30**, **-0.16)**   7446      8332                               **-0.17**   **(-0.23**, **-0.12)**   3362
  Accumulation Model*^c^*                                                                          6327                                                                              2872
   *0*                         7117    0                                                                     7117                               0.00                                 
   *1*                         7117    **-0.19**                          **(-0.31**, **-0.07)**             7117                               **-0.18**   **(-0.28**, **-0.08)**   
   *2*                         7117    **-0.38**                          **(-0.50**, **-0.26)**             7117                               **-0.30**   **(-0.40**, **-0.21)**   
   *3*                         7117    **-0.54**                          **(-0.66**, **-0.42)**             7117                               **-0.43**   **(-0.52**, **-0.33)**   
   *4*                         7117    **-0.53**                          **(-0.69**, **-0.38)**             7117                               **-0.42**   **(-0.55**, **-0.30)**   
  Sensitive Periods Model^d^                                                                       6299                                                                              2851
   *Childhood*                 7112    -0.05                              (-0.13, 0.03)                      7112                               -0.03       (-0.09, 0.04)            
   *Early Adult*               7112    **-0.35**                          **(-0.44**, **-0.26)**             7112                               **-0.25**   **(-0.32**, **-0.18)**   
   *Late Adult*                7112    -0.07                              (-0.16, 0.02)                      7112                               -0.07       (-0.14, -0.002)          
   *Current*                   7112    **-0.12**                          **(-0.20**, **-0.05)**             7112                               **-0.10**   **(-0.16**, **-0.03)**   
  Fully Saturated Model ^e^    7112                                                                6310      7112                                                                    2864

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

\* Test for interaction with sex significant at p \< 0.05 level

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age and sex but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age and sex. ^d^Mutually adjusted for SEP at other life stages and adjusted for age and sex. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age and sex

###### 

Associations of high socioeconomic position (compared to low) at four life stages with lymphocyte cell count (10^9^/L) by sex, adjusted for age^a^in 9,981 Chinese adults (≥50 years) from the Guangzhou Biobank Cohort Study, phase 3, 2006-2008 including complete cases only

                                                   Women (n = 7,445)                                   Men (n = 2,536)   
  ---------------------------- ------- ----------- ------------------------- --------- ------- ------- ----------------- ---------
                               **N**   **Δ**       **95% CI**                **AIC**   **N**   **Δ**   **95% CI**        **AIC**
                                                                                                                         
  Critical period Model^b^                                                                                               
  *Childhood*                  7207    **-0.04**   **(-0.07**, **-0.01)**    -7619     2476    0.03    (-0.03, 0.08)     -2206
  *Early Adult*                7443    **-0.08**   **(-0.11**, **-0.05)**    -7893     2533    0.03    (-0.02, 0.09)     -2274
  *Late Adult*                 6436    -0.03       (-0.07, 0.01)             -6835     2372    0.04    (-0.02, 0.09)     -2118
  *Current*                    6166    **-0.04**   **(-0.07**, **-0.01)**    -6589     2166    0.01    (-0.05, 0.06)     -1982
  Accumulation Model*^c^*                                                    -5520                                       -1783
  0                                    0.00                                            1981    0.00                      
  *1*                          5136    0.02        (-0.04, 0.07)                       1981    0.03    (-0.08, 0.13)     
  *2*                          5136    -0.04       (-0.10, 0.01)                       1981    0.07    (-0.03, 0.16)     
  *3*                          5136    **-0.10**   **(-0.15**, **-0.04)**              1981    0.08    (-0.02, 0.17)     
  *4*                          5136    **-0.07**   **(-0.14**, **-0.002)**             1981    0.07    (-0.05, 0.20)     
  Sensitive Periods Model^d^                                                 -5512                                       -1782
  *Childhood*                  5131    -0.03       (-0.06, 0.01)                       1981    0.03    (-0.03, 0.09)     
  *Early Adult*                5131    **-0.08**   **(-0.12**, **-0.04)**              1981    -0.01   (-0.08, 0.06)     
  *Late Adult*                 5131    0.02        (-0.03, 0.06)                       1981    0.03    (-0.03, 0.09)     
  *Current*                    5131    -0.01       (-0.05, 0.02)                       1981    -0.01   (-0.06, 0.05)     
  Fully Saturated Model^e^     5131                                          -7222     1981                              -7222

Abbreviations: *CI*Confidence Interval; *AIC*Akaike Information Criterion

**Bold**numbers indicate P \< 0.05 for coefficients or best fitting model for AICs

^a^Age in five year age groups. ^b^Estimates for SEP at each individual life stage adjusted for age but unadjusted for SEP at other life stages. ^c^Number of periods in high SEP adjusted for age. ^d^Mutually adjusted for SEP at other life stages and adjusted for age. ^e^Includes SEP at all four life stages and all possible interactions between all four measures of SEP. Also adjusted for age
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